Pharmacological Modulation of Cytotoxicity and Cellular Uptake of Anti-cancer Drugs by PDE5 Inhibitors in Lung Cancer Cells

Author： Li Qing   Shu Yan  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.31, Iss.1, 2014-01, pp. : 86-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1137-1143

Bentham Science Publishers

Access to resources Recommend Favorite

PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs

By  

Current Pharmaceutical Design, Vol. 16, Iss. 12, 2010-04 ,pp. : 1410-1416

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here

By  

Current Drug Metabolism, Vol. 13, Iss. 1, 2012-01 ,pp. : 4-21

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines

By Collins D.   Crown J.   O’Donovan N.   Devery A.   O’Sullivan F.   O’Driscoll L.   Clynes M.   O’Connor R.  

Investigational New Drugs, Vol. 28, Iss. 4, 2010-08 ,pp. : 433-444

Springer Publishing Company

Access to resources Recommend Favorite

Tissue Transport of Anti-cancer Drugs

By  

Current Pharmaceutical Design, Vol. 8, Iss. 22, 2002-10 ,pp. : 1987-1993

Bentham Science Publishers

Access to resources Recommend Favorite